Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps Technology, Inc. Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?
Shares of Sharps Technology Inc STSS are trading higher on Friday, with a heavy session volume of 15.17 million.
Why Is Sharps Technology (STSS) Stock Up 21% Today?
Sharps Technology (NASDAQ: STSS ) stock is up on Thursday after the medical device company announced a $30 million purchase order for its specialty copolymer prefillable syringes. Sharps Technology says this purchase order comes from Nephron Pharmaceuticals.
Why Is Sharps Technology (STSS) Stock Up 194% Today?
Sharps Technology (NASDAQ: STSS ) stock is rocketing higher on Tuesday after the company announced a potential five-year purchase agreement with Nephron. This agreement has Nephron making Sharps Technology its exclusive pre-filled copolymer syringe manufacturer.
